Genentech’s Polivy To Get US FDA Panel Review For First-Line Treatment Of Diffuse B-Cell Lymphoma

 
• By Sue Sutter
  
Magnifying glass
ODAC will scrutinize data from the POLARIX trial. • Source: Shutterstock

More from United States

More from North America